Zheng-zheng Fu
PR China
Puerto Rico
Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Consolidation therapy with decitabine and intermediate-dose cytarabine followed by HLA-mismatched peripheral blood stem cells infusion for older patients with acute myeloid leukemia in first remission.
Journal: Leukemia & lymphoma
Published: October 19, 2017
Impact of induced therapy before allogeneic hematopoietic stem-cell transplantation for higher-risk myelodysplastic syndrome: experience of single centre
Journal: Zhonghua yi xue za zhi
Published: January 11, 2014
Lower risk myelodysplastic syndrome patients with transfusion dependent treated by dose-reduced decitabine
Journal: Zhonghua yi xue za zhi
Published: January 11, 2014
The association of killer cell immunoglobulin like receptor gene polymorphism with cytomegalovirus infection after hematopoietic stem cell transplantation
Journal: Zhonghua nei ke za zhi
Published: August 24, 2013
Efficacy analysis of unrelated donor hematopoietic stem cell transplantation for treatment of high risk acute myeloid leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: July 03, 2013
The correlation of cytomegalovirus gB genotype with viral DNA load and treatment time in patients with CMV infection after hematopoietic stem cell transplantation
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: April 25, 2013
Impact of disease status on outcomes of allogeneic hematopoietic stem cell transplantation in patients with refractory and relapsed acute myeloid leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 31, 2012
Analysis of high risk factors for relapse of leukemia after allogeneic hematopoietic stem cell transplantation
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: February 21, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026